INCRUSE ELLIPTA 55 mcg POLVO PARA INHALACION UNIDOSIS

Glaxosmithkline Trading Services Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 6445919f5054630b
Drug Cima Aemps Name: INCRUSE ELLIPTA 55 mcg POLVO PARA INHALACION UNIDOSIS
Register Number: 114922002IP
Holder Company Name: Glaxosmithkline Trading Services Limited
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/glaxosmithkline-trading-services-limited
Authorization Date: 2025-10-09
Dosage Form: POLVO PARA INHALACIÓN (UNIDOSIS)
Dose: 55 microgramos
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline Trading Services Limited
Company Detail Path: /organization/glaxosmithkline-trading-services-limited

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 9, 2025

Approval ID

6445919f5054630b

Type

Standard